Project CBD

MAY 3, 2023

She is also the author of Cannabis is Medicine: How Medical Cannabis and CBD are Healing Everything from Anxiety to Chronic Pain. Dr. Goldstein will be leading the Medical Practicum at CannMed 2023 (May 15-17), where she will also be speaking about CBG and other minor cannabinoids during the main session.

Cannabinoids 216

Cannabinoids Sleep Clinical Trials CBD 216

Veriheal

SEPTEMBER 6, 2022

Synthetic cannabis and cannabinoids have been connected to adverse effects time and time again. When it comes to synthetic or semi-synthetic cannabinoids, consumers are often unaware of the potential risks that come with consuming such forms of cannabis. Examples of these are delta-8 THC , delta-10 THC , and HHC. .

Cannabinoids 98

Cannabinoids THC CBD Blood Pressure 98

MedicalJane

JUNE 12, 2020

Of the 1,276 participants, 524 adult patients and 284 adult caregivers of children or dependent adults, all self-reported using cannabis for medicinal purposes. A web-based study enrolled 1,276 participants (including those already using a cannabis product and those considering its use) between April 2016 and February 2018. Study Findings.

Chronic Pain 145

Chronic Pain Epilepsy Patients Medicine 145

MassRoots

MARCH 5, 2019

Cannabidiol ( CBD ), the non-psychoactive cannabinoid praised for medicinal powers like reducing the severity and frequency of seizures in children suffering from rare and otherwise untreatable forms of epilepsy, may not be the most medically beneficial molecule found in cannabis, according to new data. Data Tracking.

THC 111

THC CBD Data Cannabinoids 111

Sensi Seeds

DECEMBER 10, 2018

For the time being, and thanks to the onset of a new era of cannabis legalization, thousands of studies on cannabis and cannabinoids are published each year by the scientific community. Today, there is an enormous quantity and varied quality of scientific data, and this study is a fundamental tool that optimizes the way we access it.

Medicine 81

Medicine Research and Development Data Policy 81

Cannabis Law Report

JULY 27, 2021

.–(BUSINESS WIRE)– Realm of Caring (RoC) , a nonprofit dedicated to cannabinoid research, has appointed Nicolas Schlienz, Ph.D., His first initiative is co-authoring an original study on epilepsy using survey data gathered from RoC’s innovative Observational Research Registry (ORR). About Realm of Caring.

Data 81

Data Epilepsy Research and Development Clinical Trials 81

Cannabis Law Report

AUGUST 23, 2021

Oxford Cannabinoid Technologies Holdings plc. After confirmation of 6-months stability of tech-transfer batch, the work has been initiated, with preliminary data packages available by the second half of September, well within the proposed timelines. Pre-Close Trading Update; US OTC QB Market Application. &

Cannabinoids 98

Cannabinoids Research and Development Clinical Trials Packaging 98

The Cannigma

FEBRUARY 28, 2021

Physicians still don’t have enough evidence on the anti-tumor effect of cannabis, says Dr. Artur Aguiar, a radiation oncologist and pain medicine physician from Portugal. That understanding is only one of the major shifts happening in medicine with regards to cannabis and cannabinoid research. seventyfour74/123rf).

Treatment 145

Treatment Cannabinoids Hash Patients 145

Sensi Seeds

JANUARY 4, 2019

Context of the Medicinal Cannabis Situation. Under the regulations, no intermediaries are allowed to sell medicinal cannabis to patients. The Canadian medicinal cannabis regime was established in the context of illegal cannabis use. It allows patients to have access to medicinal cannabis without danger of being criminalized.

Medicine 75

Medicine Research and Development Patients Programs 75

Cannabis Chronicles

JANUARY 30, 2019

In the article — “Is Marijuana as Safe as We Think?” — writer Malcolm Gladwell focused on a 2017 report by the National Academy of Medicine that examined the scientific evidence of the health effects and therapeutic purposes of cannabis and cannabinoids. In 2017, for example, Washington had 304.5

Marijuana 124

Marijuana Data Cannabinoids Medicine 124

NORML

AUGUST 26, 2019

HB1445/SB1235, unfortunately, didn’t provide a framework for cultivating or distributing medicines, so patients had to get their cannabis from another state (a no-no under the US Department of Justice’s now-rescinded guidelines ). The certificate provides an affirmative defense for possession of those medicines.

Marijuana 244

Marijuana Legalization Programs Oil 244

FloridaMarijuana.net

SEPTEMBER 24, 2018

The European Journal of Pharmacology stated that this effect “ may represent a novel route for molecular regulation of endogenous cannabinoid activity.” This efficacy translates to better medicine and better treatments for patients. This means that as a team these compounds make cannabis stronger and more efficient. Dogwalker OG.

Terpenes 162

Terpenes Oil Strains Research and Development 162

Project CBD

FEBRUARY 27, 2023

For all modern medicine can do, many mysteries remain unsolved. “Available data strongly support the use of cannabinoids in treating fibromyalgia pain” due to “overwhelmingly positive treatment results.” What is long COVID? Is there really such thing as a “cure” for cancer? That seemed to make all the difference.

THC 144

THC CBD Clinical Trials Sleep 144

The Cannigma

FEBRUARY 2, 2021

As medicinal cannabis treatments are now legal in many parts of the world, naturally, there is a growing interest in whether the products can treat neurological conditions like Parkinson’s disease. More than 8 percent of those surveyed also reported already using cannabinoids, with 54 percent noting a beneficial clinical effect.

Patients 111

Patients Clinical Trials Research and Development Treatment 111

Cannabis Law Report

NOVEMBER 12, 2021

Neil Mahapatra is a co-founder of the Oxford Cannabinoid Technologies (OCT) which floated on the LSE in the May this year, he is also founder of UK venture capital business Kingsley Capital Partners (KCP). Oxford Cannabinoid Technologies’ Shares Fall A Further 20% As Chairman Stands Down Following Market Rule Breach.

Cannabinoids 98

Cannabinoids Clinical Trials Research and Development Pharmaceutical 98

LifeCannMD

MAY 27, 2025

#image_title By Dr. Fernando Fandio-Sende, LifeCannMD After thirty years practicing medicine and specializing as a Miami cannabis doctor , I’ve had countless conversations with patients who tell me the same thing: “Doctor, I want to try medical marijuana , but I’m scared of getting too high.”

Microdosing 52

Microdosing Research and Development Sleep Chronic Pain 52

Cannabis Law Report

JUNE 23, 2021

Sapphire Medical Clinics presented six abstracts focused on the latest research on cannabinoids based on data from the UK Medical Cannabis Registry during the 31st Annual International Cannabinoid Research Society Symposium on the Cannabinoids (ICRS2021). PROGRAMME.and.ABSTRACTS. Patient-reported outcomes.

Cannabinoids 45

Cannabinoids Data Chronic Pain Sleep 45

The Cannigma

JULY 1, 2021

The study was developed by People Science , a tech-enabled science company that is focused on connecting “health minded people, research scientists, and healthcare providers in an effort to unlock the potential of alternative medicines,” according to People Science.

Sleep 119

Sleep Edibles Research and Development Data 119

The Cannigma

FEBRUARY 24, 2022

Moreover cannabis has been used medicinally and recreationally for thousands of years. 5 William O’Shaughnessy, a medical doctor who had practiced medicine in british-occupied India, is credited as the first to bring medical cannabis over to Europe. But of course, cannabis is not solely used as medicine.

Cannabinoids 128

Cannabinoids Research and Development Conditions Cannabis 128

Veriheal

JANUARY 4, 2021

If you’re familiar with Kratom or cannabis and what their medicinal qualities are, you might be able to lend a helping hand to the man, the US Federal Government, that is. The AHRQ isn’t looking for solid input from the people in regard to the medicinal and therapeutic attributes of either of these two plants.

Chronic Pain 105

Chronic Pain Therapy Cannabinoids Treatment 105

Veriheal

FEBRUARY 28, 2023

Technology-enabled clinical research company People Science is carrying out a study into the effects of cannabinoids on sleep behavior. million, People Science plans to invest in ongoing R&D on cannabis, cannabinoids, the microbiome, psychedelics, and digital health interventions. With the additional $5.3

Sleep 52

Sleep Cannabinoids Data Food 52

Veriheal

AUGUST 15, 2022

Data was pulled from 3,922 cannabis self-administration sessions with the help of this application. Minor Cannabinoids vs. CBD and THC. Scientists know that cannabis contains a wide variety of naturally occurring chemicals other than cannabinoids. The sessions were logged by a total of 1,224 people who had access to the app.

Treatment 102

Treatment Research and Development Sativa Cannabinoids 102

Cannabis Law Report

DECEMBER 4, 2019

Based on her data, Dr. Snyder finds that requiring “Total THC” concentrations not to exceed 0.3%, rather than just limiting ?9-THC, 9-THC is commonly referred to simply as THC and is the cannabinoid known for its psychoactive effects. THCA is a non-psychoactive cannabinoid found in higher concentrations in cannabis plants.

Data 59

Data THC Strains Concentrates 59

Cannabis Law Report

MAY 10, 2022

More than half of all prescriptions for medicinal cannabis in Australia are written by doctors in Queensland, with prescriptions often given for conditions there is little evidence medicinal cannabis can treat, new research reveals. of prescriptions were for sleep disorders.

Medicine 52

Medicine Clinical Trials Data Sleep 52

Cannabis Law Report

AUGUST 24, 2022

Results from the third Cannabis as Medicine study. The third Cannabis as Medicine Survey (CAMS20) follows on from CAMS16 and CAMS18, and includes 1,600 people using medical cannabis between September 2020 and January 2021. More work is required to enhance health provider education regarding medicinal cannabis. 25 August 2022.

Medicine 52

Medicine Legalization Chronic Pain Access 52

The Cannigma

MAY 16, 2025

Every gummy, every CBD tincture, every vape pen, every cannabis recommendation is political and will be until cannabis and all its cannabinoids are federally legal. are about FDA-approved drugs vs Herbal Medicine, THC vs. no-THC, Harm Reduction vs. Prison. Cannabis is not safe from shifting political winds and regulatory clawbacks.

Policy 105

Policy Access Advocacy Patients 105

Cannabis Law Report

AUGUST 10, 2021

GW was initially granted marketing authorisation for this medicine in the UK in September 2019 as an adjunctive therapy for seizures associated with Lennox Gastaut syndrome (LGS) or Dravet syndrome, in conjunction with clobazam, for patients two years of age and older.

Pharmaceutical 98

Pharmaceutical Treatment Epilepsy Research and Development 98

Medicinal Genomics

AUGUST 5, 2019

The cannabis plant actually synthesizes cannabinoids in the acid form. This is also true for the other cannabinoids, such as CBDA, CBGA, CBCA, etc. . Researchers have found that the cannabinoid acids have their own unique pharmacological profile, which distinctly differs from their decarboxylated counterparts.

THC 16

THC Cannabinoids Data Extraction 16

Cannabis Law Report

MAY 10, 2022

First comprehensive study reveals why Australians take medicinal cannabis. First academic study of national medicinal cannabis data. The first in-depth study of Australia’s medicinal cannabis program, which began in 2016, shows the drug is being increasingly prescribed for various conditions. 11 May 2022.

Medicine 52

Medicine Clinical Trials Sleep Data 52

Veriheal

APRIL 11, 2022

The final goal is to introduce medicinal cannabis products to the pharmaceutical drug market. Groff North America is proud to be producing research-grade marijuana, so we can continue growing the field of cannabis-based medicine,” reads an official statement from the company’s website. This means that U.S.

Pharmaceutical 105

Pharmaceutical Research and Development DEA Clinical Trials 105

Cannabis Law Report

DECEMBER 16, 2019

There’s a another medicinal cannabis company with its sights on the ASX boards. Emerald Clinics captures clinical data from patients to generate evidence for the safety and efficacy of cannabis medicines. Marta Pascual Juanola.

Medicine 45

Medicine Data Safety Therapy 45

Medicinal Genomics

MARCH 27, 2019

Genetic sequencing can reveal loads of important information about a cultivar including its potential to produce certain cannabinoids, terpenoids, and flavonoids. Whole Genome Data. When it comes to sequencing your cultivar’s genetics for IP purposes, the more data the better. Publish to the Blockchain. Our Approach.

Data 94

Data Strains Terpenes Cultivation 94

StrainConnect

APRIL 23, 2019

Why Terpenes Are Vital To Your Cannabinoid Therapy. 3,4] By observing the terpene profile, cannabinoid presence and potency, and quantity of standard biomolecules like lipids and waxes, scientists can identify different chemovars. Terpenes also interact with the cannabinoids to help the therapeutic benefits take effect!

Terpenes 63

Terpenes Cannabinoids Therapy Sativa 63

Cannabis Cheri

NOVEMBER 27, 2018

THC and CBD, along with their un-decarboxylated counterparts THC-A and CBD-A (as well as cannabis’s lesser known cannabinoids) all have medical benefits when applied topically, so opt for full spectrum, whole plant when possible. Sure a lot of the cannabinoids are gone, but there are still lots left. .

Topical 188

Topical Oil Marijuana THC 188

Medical Marijuana 411

MAY 10, 2022

The post Cornell University study shows a decline in prescription medicines in US states with legal adult-use cannabis appeared first on Medical Marijuana 411. The post Cornell University study shows a decline in prescription medicines in US states with legal adult-use cannabis appeared first on Medical Marijuana 411.

Medicine 59

Medicine Legalization Sleep Data 59

Veriheal

MAY 26, 2022

But one area of cannabis medicine is still lagging behind—research. Dedicated to “redefining what’s possible,” the 501(c)(3) organization has provided 1:1 support and resources to over 69,000 clients as they navigated plant-powered cannabinoid therapy. Bringing Cannabis Into Mainstream Medicine.

Advocacy 98

Advocacy Patients Clinical Trials Education 98

The Cannigma

JUNE 15, 2021

Cannabidiol (CBD) belongs to a class of molecules called cannabinoids , which are produced almost exclusively in cannabis — hence the name. The two cannabinoids can also cause very different effects in other ways. CBD is also often compared to CBG (cannabigerol) , another increasingly popular cannabinoid. CBD vs CBDA.

CBD 122

CBD Research and Development Epilepsy Extraction 122